D VİTAMİNİ İLE KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI İLİŞKİSİ

Yıl 2020, Cilt: 5 Sayı: 1, 65 - 77, 01.04.2020

Mahir Arslan

https://doi.org/10.25279/sak.423115

Cited By: 2

Öz

İnsanlarda D vitamini
ihtiyacının %95 kadarı güneş ışınlarının etkisiyle deride sentezlenmektedir.
Mevsimler, günün saati, cam, deri koruyucular, geleneksel giyim tarzı,
yaşlanma, yaşanılan enlem bölgesi ve pigmentasyon derideki bu dönüşümü etkiler.
Vitamin D eksikliği osteoporoz ve erişkinlerde kemiğin diğer bir hastalığı
osteomalazi, çocuklarda raşitizme neden olur. Vitamin D eksikliği ayrıca
kardiyovasküler hastalık, metabolik sendrom, solunum yolu hastalıkları ve
kanserin yanında multipl skleroz, romatoid artrit, tip 1 diyabet gibi birçok otoimmün
sistem hastalığın görülme riskini artırır. Bu derlemede D vitamini ve kronik
obstrüktif akciğer hastalığı arasındaki ilişki ele alınmıştır.

Anahtar Kelimeler

D vitamini, Nonskeletal Etki, Kronik Obstrüktif Akciğer Hastalığı

Kaynakça

• (IOM) Institute of Medicine. (2011). Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: The National Academies Press.
• Adams, J. S., & Hewison, M. (2010). Update in vitamin D. J Clin Endocrinol Metab, 95(2), 471-478.
• Akpınar, E. E. (2011). Kronik obstrüktif akciğer hastalığının sistemik etkileri. Solunum Hastalıkları, 22, 107-114.
• Aranow, C. (2011). Vitamin D and the immune system. J Investig Med, 59(6), 881-886.
• Baeke, F., Takiishi, T., Korf, H., Gysemans, C., & Mathieu, C. (2010). Vitamin D: modulator of the immune system. Curr Opin Pharmacol, 10(4), 482-496.
• Baeke, F., van Etten, E., Gysemans, C., Overbergh, L., & Mathieu, C. (2008). Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities. Mol Aspects Med, 29(6), 376-387.
• Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (2008). The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A, 95(16), 9541-9546.
• Barnes, P. J., & Celli, B. R. (2009). Systemic manifestations and comorbidities of COPD. Eur Respir J, 33(5), 1165-1185.
• Barreiro, E., Fermoselle, C., Mateu-Jimenez, M., Sanchez-Font, A., Pijuan, L., Gea, J., & Curull, V. (2013). Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD. Free Radic Biol Med, 65, 859-871.
• Black, P. N., & Scragg, R. (2005). Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest, 128(6), 3792-3798.
• Bouillon, R. (2011). The Vitamin D Binding Protein DBP. In J. Adams, D. Feldman, & J. W. Pike (Eds.), Vitamin D (Third Edition) (pp. 57-72). San Diego: Academic Press.
• Bourjeily, G., & Rochester, C. L. (2000). Exercise training in chronic obstructive pulmonary disease. Clin Chest Med, 21(4), 763-781.
• Boyan, B. D., Wong, K. L., Fang, M., & Schwartz, Z. (2007). 1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. J Steroid Biochem Mol Biol, 103(3-5), 467-472.
• Bozinovski, S., Anthony, D., & Vlahos, R. (2014). Targeting pro-resolution pathways to combat chronic inflammation in COPD. J Thorac Dis, 6(11), 1548-1556.
• Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011). New insights into the immunology of chronic obstructive pulmonary disease. Lancet, 378(9795), 1015-1026.
• Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., Jensen, R. L., Marks, G. B., Gulsvik, A., Nizankowska-Mogilnicka, E., & Group, B. C. R. (2007). International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet, 370(9589), 741-750.
• Choi, C.-J., Seo, M., Choi, W.-S., Kim, K.-S., Youn, S.-A., Lindsey, T., Choi, Y.-J., & Kim, C.-M. (2013). Relationship between serum 25-hydroxyvitamin D and lung function among Korean adults in Korea National Health and Nutrition Examination Survey (KNHANES), 2008–2010. The Journal of Clinical Endocrinology & Metabolism, 98(4), 1703-1710.
• Christakos, S., Hewison, M., Gardner, D. G., Wagner, C. L., Sergeev, I. N., Rutten, E., Pittas, A. G., Boland, R., Ferrucci, L., & Bikle, D. D. (2013). Vitamin D: beyond bone. Ann N Y Acad Sci, 1287, 45-58.
• Damera, G., Fogle, H. W., Lim, P., Goncharova, E. A., Zhao, H., Banerjee, A., Tliba, O., Krymskaya, V. P., & Panettieri, R. A., Jr. (2009). Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol, 158(6), 1429-1441.
• Deluca, H. F. (2014). History of the discovery of vitamin D and its active metabolites. Bonekey Rep, 3, 479.
• Dursunoglu, N., Kokturk, N., Baha, A., Bilge, A. K., Borekci, S., Ciftci, F., Gezmen Karadag, M., Calik Kutukcu, E., Noyan, A., Polatli, M., Onen, Z. P., Sarinc, S., Umut, S., Uzaslan, E., Kubat Uzum, A., & Akkoca Yildiz, O. (2016). Comorbidities and their impact on chronic obstructive pulmonary disease. Tuberk Toraks, 64(4), 289-298.
• Franco, C. B., Paz-Filho, G., Gomes, P. E., Nascimento, V. B., Kulak, C. A., Boguszewski, C. L., & Borba, V. Z. (2009). Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int, 20(11), 1881-1887.
• GOLD. (2018). Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease 2018 Report. Retrieved from http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf
• Gosselink, R., Troosters, T., & Decramer, M. (2010). Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med, 153(3), 152-155.
• Graat-Verboom, L., van den Borne, B. E., Smeenk, F. W., Spruit, M. A., & Wouters, E. F. (2011). Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res, 26(3), 561-568.
• Grant, W. B., & Holick, M. F. (2005). Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev, 10(2), 94-111.
• Grober, U., Spitz, J., Reichrath, J., Kisters, K., & Holick, M. F. (2013). Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol, 5(3), 331-347.
• Hernigou, P., Auregan, J. C., & Dubory, A. (2018). Vitamin D: part I; from plankton and calcified skeletons (500 million years ago) to rickets. Int Orthop.
• Herr, C., Greulich, T., Koczulla, R. A., Meyer, S., Zakharkina, T., Branscheidt, M., Eschmann, R., & Bals, R. (2011). The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res, 12, 31.
• Holick, M. F. (2007). Vitamin D deficiency. N Engl J Med, 357(3), 266-281.
• Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 96(7), 1911-1930.
• Hopkinson, N. S., Li, K. W., Kehoe, A., Humphries, S. E., Roughton, M., Moxham, J., Montgomery, H., & Polkey, M. I. (2008). Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr, 87(2), 385-390.
• Horasan, G. D. (2013). Kronik Solunum Yolu Hastalıkları. In B. Ünal & G. Ergör (Eds.), Türkiye Kronik Hastalıklar ve Risk Faktörleri Sıklığı Çalışması Final Raporu (pp. 207-220). Ankara: Anıl Matbaa.
• Hornikx, M., Van Remoortel, H., Lehouck, A., Mathieu, C., Maes, K., Gayan-Ramirez, G., Decramer, M., Troosters, T., & Janssens, W. (2012). Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir Res, 13, 84.
• Janssens, W., Bouillon, R., Claes, B., Carremans, C., Lehouck, A., Buysschaert, I., Coolen, J., Mathieu, C., Decramer, M., & Lambrechts, D. (2010). Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax, 65(3), 215-220.
• Kocabas, A., Hancioglu, A., Turkyilmaz, S., & Arslan, M. (2006). Prevalence of COPD in Adana, Turkey (BOLD-Turkey Study). Proc Am Thorac Soc, 3, A543.
• Kulie, T., Groff, A., Redmer, J., Hounshell, J., & Schrager, S. (2009). Vitamin D: an evidence-based review. J Am Board Fam Med, 22(6), 698-706.
• Kunisaki, K. M., Niewoehner, D. E., Singh, R. J., & Connett, J. E. (2012). Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J, 37(2), 238-243.
• Lehouck, A., Mathieu, C., Carremans, C., Baeke, F., Verhaegen, J., Van Eldere, J., Decallonne, B., Bouillon, R., Decramer, M., & Janssens, W. (2012). High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med, 156(2), 105-114.
• Litwack, G. (2008). Human Biochemistry and Disease. Amsterdam: Elsevier.
• López‐Campos, J. L., Tan, W., & Soriano, J. B. (2016). Global burden of COPD. Respirology, 21(1), 14-23.
• Loukides, S., Bartziokas, K., Vestbo, J., & Singh, D. (2013). Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation. Curr Drug Targets, 14(2), 235-245.
• Masala, S., Magrini, A., Taglieri, A., Nano, G., Chiaravalloti, A., Calabria, E., Di Trapano, R., Pietroiusti, A., & Simonetti, G. (2014). Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP). Eur Radiol, 24(7), 1577-1585.
• McLendon, K., & Gossman, W. G. (2018). EMS, Field Identification Of Chronic Obstructive Pulmonary Disease (COPD) StatPearls. Treasure Island (FL): StatPearls Publishing LLC.
• Mohr, S. B. (2009). A brief history of vitamin d and cancer prevention. Ann Epidemiol, 19(2), 79-83.
• Nuti, R., Siviero, P., Maggi, S., Guglielmi, G., Caffarelli, C., Crepaldi, G., & Gonnelli, S. (2009). Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int, 20(6), 989-998.
• Özkan, B., & Döneray, H. (2011). D vitamininin iskelet sistemi dışı etkileri. Çocuk Sağlığı ve Hastalıkları Dergisi, 54, 99-119.
• Peter, W. J., Whitfield, G. K., Ryan, F., Shane, B., Jamie, L., & Mark, R. H. (2012). Vitamin D Vitamin D (pp. 3-36): CRC Press.
• Pilz, S., Trummer, C., Pandis, M., Schwetz, V., Aberer, F., Grubler, M., Verheyen, N., Tomaschitz, A., & Marz, W. (2018). Vitamin D: Current Guidelines and Future Outlook. Anticancer Res, 38(2), 1145-1151. doi:10.21873/anticanres.12333
• Pludowski, P., Holick, M. F., Pilz, S., Wagner, C. L., Hollis, B. W., Grant, W. B., Shoenfeld, Y., Lerchbaum, E., Llewellyn, D. J., Kienreich, K., & Soni, M. (2013). Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—A review of recent evidence. Autoimmunity Reviews, 12(10), 976-989.
• Pramyothin, P., & Holick, M. F. (2012). Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol, 28(2), 139-150.
• Rajakumar, K. (2003). Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics, 112(2), e132-135.
• Ringbaek, T., Martinez, G., Durakovic, A., Thogersen, J., Midjord, A. K., Jensen, J. E., & Lange, P. (2011). Vitamin d status in patients with chronic obstructive pulmonary disease who participate in pulmonary rehabilitation. J Cardiopulm Rehabil Prev, 31(4), 261-267.
• Semba, R. D., Chang, S. S., Sun, K., Cappola, A. R., Ferrucci, L., & Fried, L. P. (2012). Serum 25-Hydroxyvitamin D and Pulmonary Function in Older Disabled Community-Dwelling Women. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67A(6), 683-689.
• Shaheen, S. O., Jameson, K. A., Robinson, S. M., Boucher, B. J., Syddall, H. E., Sayer, A. A., Cooper, C., Holloway, J. W., & Dennison, E. M. (2011). Relationship of vitamin D status to adult lung function and COPD. Thorax, thx. 2010.155234.
• Sözen, T. (2011). D hormonu: Güncel gelişmeler. Hacettepe Tıp Dergisi, 42, 14-27.
• Tellioğlu, A., & Başaran, S. (2013). Güncel Bilgiler Işığında Vitamin D. Arşiv Kaynak Tarama Dergisi, 22(2), 259-271.
• Uzun, K., & Maden, E. (2013). KOAH’da sistemik sorunlar ve yaklaşım. Güncel Göğüs Hastalıkları Serisi, 1, 153-160.
• Visweswaran, R. K., & Lekha, H. (2013). Extraskeletal effects and manifestations of Vitamin D deficiency. Indian J Endocrinol Metab, 17(4), 602-610.
• Wacker, M., & Holick, M. F. (2013). Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol, 5(1), 51-108.
• Wen, H., & Baker, J. F. (2011). Vitamin D, immunoregulation, and rheumatoid arthritis. J Clin Rheumatol, 17(2), 102-107.
• White, J. H. (2012). Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord, 13(1), 21-29.
• WHO. (2018). Chronic obstructive pulmonary disease (COPD). Retrieved from http://www.who.int/respiratory/copd/en/
• Wimalawansa, S. J., Razzaque, M. S., & Al-Daghri, N. M. (2017). Calcium and vitamin D in human health: Hype or real? J Steroid Biochem Mol Biol.
• Wolf, G. (2004). The discovery of vitamin D: the contribution of Adolf Windaus. J Nutr, 134(6), 1299-1302.
• Zhang, L. L., Gong, J., & Liu, C. T. (2014). Vitamin D with asthma and COPD: not a false hope? A systematic review and meta-analysis. Genet Mol Res, 13(3), 7607-7616.
• Zhou, H., Wu, Y., Jin, Y., Zhou, J., Zhang, C., Che, L., Jing, J., Chen, Z., Li, W., & Shen, H. (2013). Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis. Sci Rep, 3, 2818.